Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells
Authors:
- 28 March 2023
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1808, 148354
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neuronsMolecular Brain, 2013
- Comprehensive cytogenomic profile of the in vitro neuronal model SH-SY5Yneurogenetics, 2012
- Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan – Basic Science in Relation to Migraine TreatmentHeadache: The Journal of Head and Face Pain, 2012
- Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal CordThe Journal of Neuroscience, 2009
- Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cellsMicrobiology and Immunology, 2009
- 5-Hydroxytryptamine Modulates Migration, Cytokine and Chemokine Release and T-Cell Priming Capacity of Dendritic Cells In Vitro and In VivoPLOS ONE, 2009
- History of Methysergide in MigraineCephalalgia, 2008
- Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue HypoxiaClinical Cancer Research, 2008
- 5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized ratsEuropean Journal of Pharmacology, 2007
- Functional, molecular and pharmacological advances in 5-HT receptor researchTrends in Pharmacological Sciences, 2004